ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Clinical trials for ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to save lives during sudden, deadly lung crises
Disease control Recruiting nowThis study is testing if adding intravenous immunoglobulin (IVIG) to standard hospital care helps patients with idiopathic pulmonary fibrosis (IPF) who are hospitalized for a sudden, severe worsening of their lung disease. The main goal is to see if IVIG can reduce deaths in the …
Matched conditions: ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Argyrios Tzouvelekis • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Life-or-Death trial: can common steroids save lives in sudden lung crisis?
Disease control Recruiting nowThis study aims to find out if high-dose steroid treatment helps people survive a sudden, severe worsening of idiopathic pulmonary fibrosis (IPF), a fatal lung-scarring disease. It will compare steroids against a placebo in 110 patients experiencing this crisis, where current tre…
Matched conditions: ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC